Age of children contributes to potential drug interaction at nine primary health cares

Flori R. Sari

Abstract


Introduction: Adverse drug reaction including drug interaction should be prevented early in children’s patients since children are vulnerable subjects due to their biological development process. Our study aimed to identify the potential drug interaction in children’s patients from nine primary health cares (PHC) at Tangerang.

Methods: This study was done with an analytical cross-sectional approach at nine PHC. All children patients from age 1 to 18 years old were recruited for two weeks study. All prescriptions were analyzed and categorized for potential drug interactions.

Results: We identified 19 mild and moderate but not serious potential drug interactions from 791 prescriptions (2%). The most common mild potential drug interaction is paracetamol and domperidone as well as mefenamic acid and dexamethasone for moderate potential drug interaction. Number of drugs and gender did not significantly correlate to potential drug interactions, but age did (p=0.04).

Discussion: We identified that age correlated significantly to potential drug interactions. In brief, the older the patients, the higher the possibility for the drug interactions, thus physicians should be more aware in prescribing drugs to older children’s patients.


Keywords


prescriptions; physicians; children; drug interaction; adverse drug reaction

Full Text:

PDF

References


Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255-9.

Niu J, Straubinger RM, Mager DE. Pharmacodynamic drug-drug interactions. Clin Pharmacol Ther. 2019;105(6):1395-406.

Cucinotta D, Vanelli M. WHO declares COVID‐ Benet LZ, Bowman CM, Koleske ML, Rinaldi CL, Sodhi JK. Understanding drug-drug interaction and pharmacogenomic changes in pharmacokinetics for metabolized drugs. J Pharmacokinet Pharmacodyn. 2019;46(2):155-63.

Funk RS, Brown JT, Abdel-Rahman SM. Pediatric pharmacokinetics: human development and drug disposition. Pediatr Clin North Am. 2012;59(5):1001-16.

Medina-Barajas F, Vázquez-Méndez E, Pérez-Guerrero EE, Sánchez-López VA, Hernández-Cañaveral II, Gabriel A RO, Huerta-Olvera SG. Pilot study: Evaluation of potential drug-drug interactions in hospitalized pediatric patients. Pediatr Neonatol. 2020;61(3):279-289.

Yeh ML, Chang YJ, Yeh SJ, Huang LJ, Yen YT, Wang PY, Li YC, Hsu CY. Potential drug-drug interactions in pediatric outpatient prescriptions for newborns and infants. Comput Methods Programs Biomed. 2014;113(1):15-22.

Dai D, Feinstein JA, Morrison W, Zuppa AF, Feudtner C. Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children's Hospitals. Pediatr Crit Care Med. 2016;17(5):e218-28.

Holm J, Eiermann B, Kimland E, Mannheimer B. Prevalence of potential drug-drug interactions in Swedish pediatric outpatients. PLoS One. 2019;14(8):e0220685.

Choi YH, Lee IH, Yang M, Cho YS, Jo YH, Bae HJ, Kim YS, Park JD. Clinical significance of potential drug-drug interactions in a pediatric intensive care unit: A single-center retrospective study. PLoS One. 2021;16(2):e0246754.

Sari FR, Anwar S, Risahmawati R, Fadhilah M, Ekayanti F. Bangladesh J Med Sci. 2023;22(3):667-75.

Gonzalez D, Sinha J. Pediatric Drug-Drug Interaction Evaluation: Drug, Patient Population, and Methodological Considerations. J Clin Pharmacol. 2021;61 Suppl 1(Suppl 1):S175-S187.

Henok G, Mohammed A, Feser D, Akshaya SB. Potential drug–drug interactions in pediatric wards of Gondar University Hospital, Ethiopia: A cross sectional study. Asian Pac J Trop Biomed. 2016;6(6):534-38.

Juzar SK, Khalil IA. Effect of domperidone on acetyl salicylic acid and acetaminophen absorption in rabbits, Int J Pharm. 1986:28(2–3):133-7.

Khadzhaĭ II, Navol'nev SO, Chaĭka LA. Effects of strophanthin, mefenamic acid and dexamethasone on the inflammatory and reparative processes in the heart in experimental myocarditis]. Farmakol Toksikol. 1980;43(6):697-700.

Vayalil RK, Shetty KJ, Mateti UV. Assessment of potential drug–drug interactions in an oncology unit of a tertiary care teaching hospital. Indian J Med Paediatr Oncol. 2018;39:436-42.




DOI: https://doi.org/10.15408/avicenna.v4i2.34958 Abstract - 0 PDF - 0

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

View My Stats